Protein Arginine Methyltransferase 5 Regulates Multiple Signaling Pathways to Promote Lung Cancer Cell Proliferation

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2016 Aug 3

PMID 27480244

Citations 24

Authors

Xiumei Sheng

Zhengxin Wang

Affiliations

Soon will be listed here.

Abstract

Background: Protein arginine methyltransferase 5 (PRMT5) catalyzes the formation of symmetrical dimethylation of arginine residues in proteins. WD repeat domain 77 (WDR77), also known as p44, MEP50, or WD45, forms a stoichiometric complex with PRMT5. The PRMT5/p44 complex is required for cellular proliferation of lung and prostate epithelial cells during earlier stages of development and is re-activated during prostate and lung tumorigenesis. The molecular mechanisms by which PRMT5 and p44 promote cellular proliferation are unknown.

Methods: Expression of PRMT5 and p44 in lung and prostate cancer cells was silenced and their target genes were identified. The regulation of target genes was validated in various cancer cells during lung development and tumorigenesis. Altered expression of target genes was achieved by ectopic cDNA expression and shRNA-mediated silencing.

Results: PRMT5 and p44 regulate expression of a specific set of genes encoding growth and anti-growth factors, including receptor tyrosine kinases and antiproliferative proteins. Genes whose expression was suppressed by PRMT5 and p44 encoded anti-growth factors and inhibited cell growth when ectopically expressed. In contrast, genes whose expression was enhanced by PRMT5 and p44 encoded growth factors and increased cell growth when expressed. Altered expression of target genes is associated with re-activation of PRMT5 and p44 during lung tumorigenesis.

Conclusions: Our data provide the molecular basis by which PRMT5 and p44 regulate cell growth and lay a foundation for further investigation of their role in lung tumor initiation.

Citing Articles

Targeting epigenetic alterations in cancer stem cells.

F V, V D P, C M, M L, C D, G P Front Mol Med. 2024; 2:1011882.

PMID: 39086963 PMC: 11285701. DOI: 10.3389/fmmed.2022.1011882.

PRMT1 and PRMT5: on the road of homologous recombination and non-homologous end joining.

Yin S, Liu L, Gan W Genome Instab Dis. 2023; 4(4):197-209.

PMID: 37663901 PMC: 10470524. DOI: 10.1007/s42764-022-00095-w.

Structure-Based Discovery and Biological Assays of a Novel PRMT5 Inhibitor for Non-Small Cell Lung Cancer.

Chen Y, Zhang M, Wu A, Yao X, Wang Q Molecules. 2022; 27(21).

PMID: 36364261 PMC: 9656811. DOI: 10.3390/molecules27217436.

Cryo-EM structure-based selection of computed ligand poses enables design of MTA-synergic PRMT5 inhibitors of better potency.

Zhou W, Yadav G, Yang X, Qin F, Li C, Jiang Q Commun Biol. 2022; 5(1):1054.

PMID: 36192627 PMC: 9530242. DOI: 10.1038/s42003-022-03991-9.

The Structure and Functions of PRMT5 in Human Diseases.

Motolani A, Martin M, Sun M, Lu T Life (Basel). 2021; 11(10).

PMID: 34685445 PMC: 8539453. DOI: 10.3390/life11101074.

References

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Yi P, Gao S, Gu Z, Huang T, Wang Z . P44/WDR77 restricts the sensitivity of proliferating cells to TGFβ signaling. Biochem Biophys Res Commun. 2014; 450(1):409-15. DOI: 10.1016/j.bbrc.2014.05.125. View

Pal S, Vishwanath S, Erdjument-Bromage H, Tempst P, Sif S . Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol. 2004; 24(21):9630-45. PMC: 522266. DOI: 10.1128/MCB.24.21.9630-9645.2004. View

Hsu J, Chen C, Chou C, Kuo H, Li L, Lin C . Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat Cell Biol. 2011; 13(2):174-81. PMC: 3048027. DOI: 10.1038/ncb2158. View

Bedford M, Richard S . Arginine methylation an emerging regulator of protein function. Mol Cell. 2005; 18(3):263-72. DOI: 10.1016/j.molcel.2005.04.003. View

Eisen M, Spellman P, Brown P, Botstein D . Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998; 95(25):14863-8. PMC: 24541. DOI: 10.1073/pnas.95.25.14863. View

Bedford M, Clarke S . Protein arginine methylation in mammals: who, what, and why. Mol Cell. 2009; 33(1):1-13. PMC: 3372459. DOI: 10.1016/j.molcel.2008.12.013. View

Zhang B, Dong S, Zhu R, Hu C, Hou J, Li Y . Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3. Oncotarget. 2015; 6(26):22799-811. PMC: 4673200. DOI: 10.18632/oncotarget.4332. View

Sierke S, Cheng K, Kim H, Koland J . Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein. Biochem J. 1997; 322 ( Pt 3):757-63. PMC: 1218252. DOI: 10.1042/bj3220757. View

10.

Pal S, Baiocchi R, Byrd J, Grever M, Jacob S, Sif S . Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO J. 2007; 26(15):3558-69. PMC: 1949000. DOI: 10.1038/sj.emboj.7601794. View

11.

Jakt L, Cao L, Cheah K, Smith D . Assessing clusters and motifs from gene expression data. Genome Res. 2001; 11(1):112-23. PMC: 311053. DOI: 10.1101/gr.148301. View

12.

Gu Z, Gao S, Zhang F, Wang Z, Ma W, Davis R . Protein arginine methyltransferase 5 is essential for growth of lung cancer cells. Biochem J. 2012; 446(2):235-41. PMC: 3865921. DOI: 10.1042/BJ20120768. View

13.

Wang L, Pal S, Sif S . Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol Cell Biol. 2008; 28(20):6262-77. PMC: 2577430. DOI: 10.1128/MCB.00923-08. View

14.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

15.

Cho E, Zheng S, Munro S, Liu G, Carr S, Moehlenbrink J . Arginine methylation controls growth regulation by E2F-1. EMBO J. 2012; 31(7):1785-97. PMC: 3321197. DOI: 10.1038/emboj.2012.17. View

16.

Friesen W, Wyce A, Paushkin S, Abel L, Rappsilber J, Mann M . A novel WD repeat protein component of the methylosome binds Sm proteins. J Biol Chem. 2002; 277(10):8243-7. DOI: 10.1074/jbc.M109984200. View

17.

Hellyer N, Cheng K, Koland J . ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase. Biochem J. 1998; 333 ( Pt 3):757-63. PMC: 1219642. DOI: 10.1042/bj3330757. View

18.

Le Guezennec X, Vermeulen M, Brinkman A, Hoeijmakers W, Cohen A, Lasonder E . MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol. 2006; 26(3):843-51. PMC: 1347035. DOI: 10.1128/MCB.26.3.843-851.2006. View

19.

Ren J, Wang Y, Liang Y, Zhang Y, Bao S, Xu Z . Methylation of ribosomal protein S10 by protein-arginine methyltransferase 5 regulates ribosome biogenesis. J Biol Chem. 2010; 285(17):12695-705. PMC: 2857073. DOI: 10.1074/jbc.M110.103911. View

20.

Aggarwal P, Vaites L, Kim J, Mellert H, Gurung B, Nakagawa H . Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell. 2010; 18(4):329-40. PMC: 2957477. DOI: 10.1016/j.ccr.2010.08.012. View